glp-1 levels in type 2 diabetes receptor agonists for individualized treatment of mellitus GLP-1 for Weight Loss and

NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer

We thank the Genomics Facility (RRID:SCR_021727), Imaging facility (RRID:SCR_021741), and Proteomics and Metabolomics facility (RRID:SCR_021743) of the Biotechnology Resource Center (BRC) of Cornell Institute of Biotechnology for RNA-sequencing, Imaging and lipidomic experiments, respectively

A role for Glucagon-Like Peptide-1 in the regulation of -cell autophagy

Clinical assessments and laboratory analyses were performed 3 and 6 months after randomization along with assessment of patient compliance to study drug and recommendations concerning physical activity and diet

3T3-L1 adipocytes were treated with exendin-4 at 0, 1.25 nM, 2.5 nM, and 5 nM for 6 hours, 12 hours, 24 hours, and 48 hours, respectively